The University of Chicago Header Logo

Connection

Mark J. Ratain to Depsipeptides

This is a "connection" page, showing publications Mark J. Ratain has written about Depsipeptides.
Connection Strength

0.517
  1. First-in-human, phase I study of elisidepsin (PM02734) administered as a 30-min or as a 3-hour intravenous infusion every three weeks in patients with advanced solid tumors. Invest New Drugs. 2015 Aug; 33(4):901-10.
    View in: PubMed
    Score: 0.517
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.